Top-spending pharma advertisers for 2016: J&J, Pfizer, Roche and Novartis

Pharma ad budgets may be set to dip overall in 2016, but the industry's big spenders will still be shelling out $2 billion each--or more--to promote their drugs, according to an annual spending study. Johnson & Johnson ($JNJ) is expected to lead the way with a 4.6% hike in spending, with Pfizer ($PFE), Roche ($RHHBY) and Novartis ($NVS) following behind. More from FiercePharmaMarketing